High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission.
about
The role of targeted treatment in mantle cell lymphoma: is transplant dead or alive?Cisplatin, fludarabine, and cytarabine: a novel, pharmacologically designed salvage therapy for patients with refractory, histologically aggressive or mantle cell non-Hodgkin's lymphoma.Evaluation of the (R)VAD+C regimen for the treatment of newly diagnosed mantle cell lymphoma. Combined results of two prospective phase II trials from the French GOELAMS groupTemsirolimus in the treatment of relapsed or refractory mantle cell lymphoma.Stem cell transplantation for mantle cell lymphoma: should it ever be used outside clinical trials?Rituximab: enhancing stem cell transplantation in mantle cell lymphoma.Mantle cell lymphoma: a biological and therapeutic paradigm.Current treatment options in aggressive lymphoma.A phase 1/2 trial of high-dose yttrium-90-ibritumomab tiuxetan in combination with high-dose etoposide and cyclophosphamide followed by autologous stem cell transplantation in patients with poor-risk or relapsed non-Hodgkin lymphomaStem cell transplantation for mantle cell lymphoma: if, when and how?Targeting the proteasome in mantle cell lymphoma: a promising therapeutic approach.Specific features identify patients with relapsed or refractory mantle cell lymphoma benefitting from autologous hematopoietic cell transplantation.Long-term survival and late relapse in 2-year survivors of autologous haematopoietic cell transplantation for Hodgkin and non-Hodgkin lymphoma.Effect of remission status and induction chemotherapy regimen on outcome of autologous stem cell transplantation for mantle cell lymphoma.Autologous and allogeneic stem cell transplantation: rising therapeutic promise for mantle cell lymphoma.Mantle cell lymphoma: state-of-the-art management and future perspective.Clinical practice guidelines for diagnosis, treatment, and follow-up of patients with mantle cell lymphoma. Recommendations from the GEL/TAMO Spanish Cooperative Group.Current treatment strategies in relapsed/refractory mantle cell lymphoma: where are we now?How I treat mantle cell lymphoma.Seventy-two hour continuous infusion flavopiridol in relapsed and refractory mantle cell lymphoma.Response to thalidomide in chemotherapy-resistant mantle cell lymphoma: a case report.Paramount therapy for young and fit patients with mantle cell lymphoma: strategies for front-line therapy.
P2860
Q26772907-BB7DAC6E-A826-4107-B0C6-8114547A0653Q33341143-666B1000-38EB-40B4-8EEE-E38BF57EA192Q33388563-20CD44BB-02B7-4E9D-B6E1-54A2589D1C46Q34129360-EEEB093F-BBAB-4657-B6C5-00A8B4B3B9DEQ34487427-4DC50004-8536-4118-BF30-9E4029F88456Q34526387-68D07C4D-DEC9-4E31-99AC-865A7ECA164DQ34769876-70EC6803-712D-4039-9883-BB14EFE2D27FQ35778926-16A2151D-E107-4B09-95A8-F089B1D012AEQ35848351-051BD778-C1E1-4C64-BD4B-532BCFAE2C31Q36188687-8F999EF1-1EA8-4D7B-ADC1-E7B15FE8EF30Q36328428-FEC4C731-6828-4738-82CE-72E2F5BC94B4Q37210817-C0AB2CFB-1147-4E59-877B-93393485C668Q37356389-378B808F-FC09-482F-9608-0CB273A63699Q37402853-3A26C97A-EA14-4BD1-931C-80398685F1E8Q37534547-D16325AC-5761-4561-A458-1525DB70C409Q37622873-19949151-8651-4E4C-BE3E-18C83565B215Q38110232-303AB89C-D2D5-45DE-B116-57D2EC57F909Q39044162-79FE2401-DFE2-4626-B6AE-8562B04B543AQ41988762-E9B0F792-2D6A-4ED4-BDD4-5078D0829C6DQ44086086-33944880-DD90-4904-BD68-CDC3025B855DQ44163487-9944B277-9D45-4F72-AFF9-FDF8CA72F44AQ55610546-0B0F56B2-E082-484F-B9C0-FC2B147B23CC
P2860
High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
High-dose chemoradiotherapy an ...... dence for long-term remission.
@en
type
label
High-dose chemoradiotherapy an ...... dence for long-term remission.
@en
prefLabel
High-dose chemoradiotherapy an ...... dence for long-term remission.
@en
P2093
P356
P1476
High-dose chemoradiotherapy an ...... dence for long-term remission.
@en
P2093
A S Freedman
D C Fisher
J G Gribben
K C Anderson
L M Nadler
N Andersen
P356
10.1200/JCO.1998.16.1.13
P407
P577
1998-01-01T00:00:00Z